Julie Klemens, CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7233 Whipple Ave Nw, North Canton, OH 44720 Phone: 330-498-8200 |
Chandley Hephner, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 339 E Maple St, North Canton, OH 44720 Phone: 330-498-8239 |
Michelle Marian Pickett, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6057 Strip Ave Nw, North Canton, OH 44720 Phone: 330-492-8136 |
Alyssa J Bailey, CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7171 Keck Park Cir Nw, North Canton, OH 44720 Phone: 330-498-8200 |
Emily Greene, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7233 Whipple Ave Nw, North Canton, OH 44720 Phone: 330-498-8200 |
Carolyn Chimera Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3397 Ramsgate St Nw, North Canton, OH 44720 Phone: 330-966-3187 |
Mrs. Faith Christine Bettilyon, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6057 Strip Ave Nw, North Canton, OH 44720 Phone: 330-492-8136 |
Sarah E Suchanek, SLP-CFY Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 339 E Maple St, North Canton, OH 44720 Phone: 330-498-8200 |
Megan R Hummel Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7171 Keck Park Cir Nw, North Canton, OH 44720 Phone: 330-498-5222 |
Stephanie Baker, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7235 Whipple Ave Nw, North Canton, OH 44720 Phone: 330-498-8200 |
Christy Uhren Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7233 Whipple Ave Nw, North Canton, OH 44720 Phone: 330-498-8200 |
Mrs. Danielle Ann Rogich Smith, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7233 Whipple Ave Nw, North Canton, OH 44720 Phone: 330-498-8200 |
Joan Schick Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7233 Whipple Ave Nw, North Canton, OH 44720 Phone: 330-498-8200 |
Michelle L Batchelor, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7235 Whipple Ave Nw, North Canton, OH 44720 Phone: 330-498-8200 |
Lauren Bauman, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7235 Whipple Ave Nw, North Canton, OH 44720 Phone: 330-418-9313 |
Kimberly Click, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 339 E Maple St, North Canton, OH 44720 Phone: 330-498-8200 |
Tiffany J Lucas, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7171 Keck Park Cir Nw, North Canton, OH 44720 Phone: 330-498-8200 |
Julie Frank, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7233 Whipple Ave Nw, North Canton, OH 44720 Phone: 330-498-8200 |
Dennis P Rubano, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7235 Whipple Ave Nw, North Canton, OH 44720 Phone: 330-498-8200 |
Samantha Nartker, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 339 E Maple St, North Canton, OH 44720 Phone: 330-498-8200 |
News Archive
Accelovance, a therapeutically focused clinical research organization (CRO), announced today the opening of a new office in Research Triangle Park (RTP), North Carolina.
Copayment Reductions Generate Greater Medication Adherence In Targeted Patients. As health care costs have increased, some patients have sought to save money by cutting down on their medications.
A research collaboration between the Wyss Institute for Biologically Inspired Engineering at Harvard University and Children's Hospital Boston has developed "smart" injectable nanotherapeutics that can be programmed to selectively deliver drugs to the cells of the pancreas. Although this nanotechnology will need significant additional testing and development before being ready for clinical use, it could potentially improve treatment for Type I diabetes by increasing therapeutic efficacy and reducing side effects.
A survey conducted by Johns Hopkins faculty found strong support among their peers for working more closely with the minority, inner-city community that surrounds the institution. Overall, 91 percent of faculty responders said closer ties make research more relevant to those it ultimately serves, and 87 percent said it improves the quality of research.
Australian biopharmaceutical company Specialised Therapeutics Australia announces that a phase III clinical trial of world leading breast cancer drug ABRAXANE (nanoparticle albumin-bound paclitaxel) in combination with current standard of care gemcitabine in patients with advanced pancreatic cancer has demonstrated substantially improved survival times, with double the number of patients surviving two years.
› Verified 9 days ago